Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C + NK cells to target myeloid leukemia.

Emily Chiu, Martin Felices, Frank Cichocki, Zachary Davis, Hongbo Wang, Katie Tuninga, Daniel A. Vallera, Tom Lee, Ryan Bjordahl, Karl Johan Malmberg, Bahram Valamehr, Jeffrey S. Miller

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C + NK cells to target myeloid leukemia.'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds